Warning-
Disclaimer– Registration granted by SEBI, membership of a SEBI recognized supervisory body (BSE) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Disclosure– Investments in securities market are subject to market risks, read all the related documents carefully before investing.
Sun Pharma is trading in a steady uptrend, holding firmly above its 20-day and 50-day moving averages, showing strong momentum. The stock recently formed higher lows, indicating sustained buying on dips. RSI is in a healthy bullish zone without overbought stress, supporting continuation of the trend. As long as it holds above ₹1715–1725 support, the structure stays positive for a move toward ₹1790–1810.
Comments
One response to “BUY : SUNPHARMA25NOV251740CE( SUNPHARMA ) [146328]”
TARGET ACHIEVED